| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...513091S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0013091 |
| P932 | PMC publication ID | 2948500 |
| P698 | PubMed publication ID | 20957034 |
| P5875 | ResearchGate publication ID | 47459967 |
| P50 | author | Tymon Rubel | Q41204649 |
| Michal Mikula | Q41204665 | ||
| Jerzy Ostrowski | Q41204676 | ||
| Krzysztof Goryca | Q91550636 | ||
| Magdalena Skrzypczak | Q58329145 | ||
| Agnieszka Paziewska | Q89454650 | ||
| P2093 | author name string | Janusz Oledzki | |
| Jacek Pachlewski | |||
| Dorota Jarosz | |||
| P2860 | cites work | Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset | Q21184169 |
| A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential | Q24310649 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Correlation test to assess low-level processing of high-density oligonucleotide microarray data | Q24791325 | ||
| A comparison of normalization methods for high density oligonucleotide array data based on variance and bias | Q27860710 | ||
| Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection | Q27860727 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| Patterns of somatic mutation in human cancer genomes | Q29547841 | ||
| A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes | Q29618085 | ||
| A review of independent component analysis application to microarray gene expression data | Q30478037 | ||
| Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. | Q30666300 | ||
| Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues | Q31145480 | ||
| A comprehensive re-analysis of the Golden Spike data: towards a benchmark for differential expression methods | Q31150638 | ||
| Gene expression pattern of laser microdissected colonic crypts of adenomas with low grade dysplasia | Q33187757 | ||
| Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. | Q33244472 | ||
| Normalization of oligonucleotide arrays based on the least-variant set of genes | Q33322408 | ||
| Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis | Q33376051 | ||
| Analyzing time-dependent microarray data using independent component analysis derived expression modes from human macrophages infected with F. tularensis holartica | Q33470073 | ||
| Genetic pathways in colorectal and other cancers | Q33711610 | ||
| Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. | Q33723633 | ||
| mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray | Q33865879 | ||
| Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray | Q34781618 | ||
| Expression profiling by microarrays in colorectal cancer (Review). | Q36038442 | ||
| Transcriptome amplification methods in gene expression profiling | Q36481141 | ||
| Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas | Q36487084 | ||
| Expression and genomic profiling of colorectal cancer | Q36607688 | ||
| Cancer genetics: a primer for surgeons | Q37232250 | ||
| Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature | Q37307868 | ||
| Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives | Q37350278 | ||
| Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. | Q37592256 | ||
| Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results | Q38360197 | ||
| Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumors | Q41909750 | ||
| A benchmark for Affymetrix GeneChip expression measures | Q47207948 | ||
| Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. | Q52065686 | ||
| Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. | Q53314758 | ||
| Transcriptome profile of human colorectal adenomas. | Q53325472 | ||
| Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. | Q53370638 | ||
| Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. | Q53676771 | ||
| Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures. | Q54586486 | ||
| Gene expression in colorectal cancer | Q74558243 | ||
| Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics | Q80114123 | ||
| Identification of gene signatures for invasive colorectal tumor cells | Q81440883 | ||
| Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications | Q81448413 | ||
| Network-based prediction of human tissue-specific metabolism | Q81798711 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | affy | Q113334509 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | data quality | Q1757694 |
| P304 | page(s) | e1000938 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability | |
| P478 | volume | 5 |
| Q92882068 | A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches |
| Q38383767 | A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome. |
| Q35091466 | A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer. |
| Q83228146 | A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS |
| Q52670834 | AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression. |
| Q40178846 | ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells |
| Q64279631 | Aberrant activation of CYR61 enhancers in colorectal cancer development |
| Q37078707 | Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis |
| Q34455378 | An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer |
| Q39022069 | Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity. |
| Q92861943 | Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer |
| Q38711176 | Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma |
| Q46757330 | Associations between novel genetic variants in the promoter region of MALAT1 and risk of colorectal cancer |
| Q94474146 | Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer |
| Q90480397 | Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers |
| Q58798715 | Bioinformatics Analysis Reveals Most Prominent Gene Candidates to Distinguish Colorectal Adenoma from Adenocarcinoma |
| Q89553060 | C20orf27 Promotes Cell Growth and Proliferation of Colorectal Cancer via the TGFβR-TAK1-NFĸB Pathway |
| Q38966986 | CDC42 inhibition suppresses progression of incipient intestinal tumors |
| Q28386541 | Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formation |
| Q64102496 | Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway |
| Q33779451 | Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma |
| Q91693306 | Colon Cancer and Perturbations of the Sphingolipid Metabolism |
| Q52620979 | Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism. |
| Q35713627 | Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis. |
| Q42250395 | Comparative kinome analysis to identify putative colon tumor biomarkers |
| Q91787579 | Comparative lipidomics of 5-Fluorouracil-sensitive and -resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1) |
| Q61757399 | Consensus molecular subtype classification of colorectal adenomas |
| Q37659446 | Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis |
| Q35973348 | Cooperation of the BTB-Zinc finger protein, Abrupt, with cytoskeletal regulators in Drosophila epithelial tumorigenesis |
| Q37564748 | Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis |
| Q36581878 | Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas |
| Q42676794 | DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy |
| Q47113908 | Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt/β-catenin signaling confers anti-apoptotic properties to colorectal cancer cells |
| Q36887543 | Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study |
| Q38755951 | Depletion of UBA protein 2-like protein inhibits growth and induces apoptosis of human colorectal carcinoma cells |
| Q41348887 | Dicer suppresses cytoskeleton remodeling and tumorigenesis of colorectal epithelium by miR-324-5p mediated suppression of HMGXB3 and WASF-2. |
| Q34826294 | Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis |
| Q28273187 | Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome |
| Q38634944 | Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells. |
| Q58694406 | Down-regulation of CXCL 11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition |
| Q55007013 | Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2. |
| Q36954842 | Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer |
| Q33640340 | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
| Q40206148 | Epigenetic-Mediated Downregulation of μ-Protocadherin in Colorectal Tumours. |
| Q36962421 | Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma |
| Q64890227 | Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer. |
| Q48364515 | Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer. |
| Q51554706 | Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer. |
| Q41702549 | Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers |
| Q41817645 | Expression changes of cell-cell adhesion-related genes in colorectal tumors. |
| Q92557108 | Expression of septin 2 and association with clinicopathological parameters in colorectal cancer |
| Q36545181 | Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components |
| Q90706035 | Four targeted genes for predicting the prognosis of colorectal cancer: A bioinformatics analysis case |
| Q35702425 | Gene Expression Signatures Based on Variability can Robustly Predict Tumor Progression and Prognosis |
| Q39309657 | Gene expression of the lysophosphatidic acid receptor 1 is a target of transforming growth factor beta |
| Q37343279 | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
| Q55426160 | Genome data uncover four synergistic key regulators for extremely small body size in horses. |
| Q35214688 | HSP105 recruits protein phosphatase 2A to dephosphorylate β-catenin. |
| Q39165217 | Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth |
| Q53961022 | High expression of WWP1 predicts poor prognosis and associates with tumor progression in human colorectal cancer. |
| Q92382964 | High expression of eukaryotic initiation factor 3M predicts poor prognosis in colon adenocarcinoma patients |
| Q41204585 | Histone H3 lysine 27 acetylation is altered in colon cancer |
| Q28511495 | Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis |
| Q27330207 | ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis |
| Q35616286 | IL-33 activates tumor stroma to promote intestinal polyposis. |
| Q36879136 | IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer. |
| Q90705921 | Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer |
| Q33850029 | Identification of RING-box 2 as a potential target for combating colorectal cancer growth and metastasis |
| Q34051993 | Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer |
| Q41338135 | Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. |
| Q92382651 | Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis |
| Q30878074 | Identifying cancer-related microRNAs based on gene expression data |
| Q31155155 | Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response |
| Q92423962 | ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors |
| Q33715089 | In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer |
| Q35919227 | Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. |
| Q41476618 | Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1. |
| Q91386693 | Indispensable role of STIL in the regulation of cancer cell motility through the lamellipodial accumulation of ARHGEF7-PAK1 complex |
| Q39816968 | Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling |
| Q45981687 | Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. |
| Q99238575 | Integrative Analysis of the IQ Motif-Containing GTPase-Activating Protein Family Indicates That the IQGAP3-PIK3C2B Axis Promotes Invasion in Colon Cancer |
| Q33888701 | Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells |
| Q37083757 | Intestinal iron homeostasis and colon tumorigenesis |
| Q61445424 | JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer |
| Q41593124 | Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells |
| Q97644876 | KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway |
| Q37609828 | KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties |
| Q36069877 | Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling |
| Q35981404 | Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors. |
| Q37687424 | Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation |
| Q37672680 | Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions |
| Q47661261 | Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence |
| Q36105658 | Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer |
| Q38839830 | MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy |
| Q61446372 | MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex |
| Q92673161 | MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer |
| Q26825295 | Matrix metalloproteinases in stem cell regulation and cancer |
| Q49315313 | Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase α. |
| Q35683329 | Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients |
| Q41955998 | Meta-analysis of the expression of the mitosis-related gene Fam83D. |
| Q42267976 | Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer |
| Q64265687 | Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit |
| Q64092236 | MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1 |
| Q33593399 | Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays |
| Q34776090 | Mining CK2 in cancer |
| Q34639059 | Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker |
| Q33918398 | Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling. |
| Q37684426 | Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer |
| Q64098709 | Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer |
| Q34544632 | Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell lines |
| Q37190361 | Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects |
| Q38977664 | Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist. |
| Q37519069 | NQO1 inhibits proteasome-mediated degradation of HIF-1α. |
| Q36545813 | OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer |
| Q47143491 | Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA. |
| Q33838577 | Oncogenic protein MTBP interacts with MYC to promote tumorigenesis |
| Q39651723 | Overexpression of GRO-β is associated with an unfavorable outcome in colorectal cancer |
| Q33779573 | Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer |
| Q47106112 | Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance |
| Q90693015 | PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer |
| Q55023889 | PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development. |
| Q87417418 | PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer |
| Q24337364 | PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice |
| Q33594693 | PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling |
| Q97692511 | PRMT5 promotes cancer cell migration and invasion through the E2F pathway |
| Q41721009 | Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration. |
| Q34140323 | Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas |
| Q43238527 | Protective Role for TWEAK/Fn14 in Regulating Acute Intestinal Inflammation and Colitis-Associated Tumorigenesis |
| Q90219718 | Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases |
| Q36747368 | Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer |
| Q47758650 | R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis |
| Q57782091 | RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer |
| Q37600049 | Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. |
| Q38876701 | Reproducibility of parameter learning with missing observations in naive Wnt Bayesian network trained on colorectal cancer samples and doxycycline-treated cell lines. |
| Q36545820 | Revealing potential molecular targets bridging colitis and colorectal cancer based on multidimensional integration strategy |
| Q39031608 | Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis |
| Q33688934 | Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer |
| Q33750953 | SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer |
| Q57046560 | SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells |
| Q40953655 | Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer |
| Q38982072 | Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells |
| Q41309461 | Skp1-Cul1-F-box ubiquitin ligase (SCF(βTrCP))-mediated destruction of the ubiquitin-specific protease USP37 during G2-phase promotes mitotic entry |
| Q36557469 | Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics |
| Q92598503 | Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer |
| Q33688989 | Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer |
| Q37593943 | Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients |
| Q37267647 | TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway |
| Q52726523 | TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer. |
| Q38880075 | Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer |
| Q36153315 | Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis |
| Q89471669 | Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level |
| Q104795301 | The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer |
| Q37738063 | The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression |
| Q96304342 | The expression profiles and prognostic values of HSPs family members in Head and neck cancer |
| Q37664636 | The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer |
| Q37706211 | The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers |
| Q41626594 | Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. |
| Q90699399 | Transcription levels and prognostic significance of the NFI family members in human cancers |
| Q34412672 | Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer |
| Q41093090 | TrkC promotes colorectal cancer growth and metastasis |
| Q36723450 | Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis. |
| Q34500249 | Vitamin D and colon cancer. |
| Q90370797 | YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer |
| Q64117473 | mA-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1 |
| Q36837231 | miR-23a promotes the transition from indolent to invasive colorectal cancer |
| Q47148722 | miR19b-3p promotes the growth and metastasis of colorectal cancer via directly targeting ITGB8. |
| Q98386357 | γ-H2AX as a potential indicator of radiosensitivity in colorectal cancer cells |
Search more.